logo
Select company
Select metric
-1.18%Operating Cash Flow Margin
VS
Market
26
Sector
60
Industry
84
History
88
$ 2.93Close
$ 1.33 - $ 4.01 52-Week Range
Ticker Information

Ticker

AKBA

Company Name

AKEBIA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AKEBIA THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AKBA - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -2.4M-1.18%$ 203.73M
3/31/2025$ -34.81M-18.83%$ 184.91M
12/31/2024$ -40.66M-25.38%$ 160.18M
9/30/2024$ -38.5M-22.66%$ 169.88M
6/30/2024$ -38.97M-22.33%$ 174.5M
3/31/2024$ -25.28M-13.5%$ 187.22M
12/31/2023$ -23.38M-12.02%$ 194.62M
9/30/2023$ -75.75M-39.13%$ 193.61M
6/30/2023$ -34.78M-17.35%$ 200.53M
3/31/2023$ -69.07M-25.49%$ 271.03M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AKEBIA THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -55.73%.
  • Over the past 5 years, AKEBIA THERAPEUTICS INC's average OCF % has been -41.88%.
  • The median OCF % for AKEBIA THERAPEUTICS INC during this period was -26.43%
  • AKEBIA THERAPEUTICS INC reached its highest OCF % over the past 5 years at -1.18%.
  • The lowest OCF % recorded by AKEBIA THERAPEUTICS INC in the same timeframe -118.44%

AKEBIA THERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
STOK : STOKE THERAPEUTICS INC 30.81%DNA : GINKGO BIOWORKS HOLDINGS INC -102.99%DAWN : DAY ONE BIOPHARMACEUTICALS INC -33.61%GERN : GERON CORP -108.41%IOVA : IOVANCE BIOTHERAPEUTICS INC -125.62%MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -9.8%KROS : KEROS THERAPEUTICS INC 23.64%CRMD : CORMEDIX INC 25.08%NAGE : NIAGEN BIOSCIENCE INC 18.24%ZYME : ZYMEWORKS INC -31.51%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for AKEBIA THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -171.74M ] / Revenues [ $ 308.16M ]
(=) OCF % [ -55.73% ]

AKBA - Operating Cash Flow Margin, Last 5 years

-118.44%

Minimum

Dec 31, 2021

-1.18%

Maximum

Jun 30, 2025

-41.88%

Average

-26.43%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%